What Has Been Urethral Stricture Treatment Devices Market in Recent Years?
The urethral stricture treatment devices market has seen considerable growth due to a variety of factors.
• In recent years, there has been significant growth in the market size of urethral stricture treatment devices. The market is forecasted to experience growth from $1.37 billion in 2024 to $1.48 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.3%.
The notable growth observed during the historic period could be credited to factors such as an increased occurrence of urethral strictures, a heightened level of acceptance of minimally invasive treatments, a spike in awareness of urological disorders, as well as an upsurge in healthcare spending in developed regions, and enhanced diagnostic capabilities.
What is the Market Size Forecast for the Urethral Stricture Treatment Devices Market?
The urethral stricture treatment devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for urethral stricture treatment devices is projected to experience robust growth in the coming years, reaching $2.01 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%.
This predicted growth throughout the forecast period can be credited to factors such as the increasing requirement for outpatient procedures, a growing emphasis on delivering patient-focused care, the development of healthcare facilities in new markets, a rise in incidents related to trauma-derived strictures, and awareness programs established by healthcare bodies. Key trends expected throughout the forecast period include a migration towards less invasive surgical procedures, the incorporation of Artificial Intelligence in diagnostic tools, advancements in the technology of surgical devices, progress in medical imaging methods, and a concentrated focus on customized treatment plans.
What Are The Key Drivers Fueling Growth In The Urethral Stricture Treatment Devices Market?
The escalating incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder is predicted to spur growth in the urethral stricture treatment devices market. BPH, common in older males, causes the prostate gland to increase in size, leading to urinary obstruction and elevating the risk of urethral strictures. This increased incidence in BPH is mainly attributed to advancing age, mainly affecting men over 50 years, while lifestyle, hormonal shifts, and chronic diseases also fuel its development. Urethral stricture treatment devices find their use in managing urological conditions like BPH, where complications following surgery or long-term catheterization can cause urethral constriction, necessitating interventions such as dilators, stents, or urethrotomy tools to re-establish normal urine flow. For example, according to a report by the Royal Pharmaceutical Society, a professional body based in the UK, in September 2023, approximately 3 million individuals in the UK are struggling with BPH, with prevalence rates reaching 50% in males aged 60–70 years and soaring to 90% in males over 80 years. Thus, the increasing incidence of BPH and neurogenic bladder will propel the urethral stricture treatment device market.
What Are The Major Segments Within The Urethral Stricture Treatment Devices Market?
The urethral stricture treatment devices market covered in this report is segmented –
1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters
Pre-Book The Urethral Stricture Treatment Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Urethral Stricture Treatment Devices Market?
In an effort to enhance technological integration and broaden their market reach, major businesses in the urethral stricture treatment devices industry are adopting a partnering strategy. Strategic partnerships denote cooperative relations between multiple organizations, blending their individual resources, proficiency, and endeavors to fulfil mutual goals. For example, April 2024 witnessed Laborie Medical Technologies Corp., a medical technology corporation based in the U.S., joining hands with the NHS Specialized Services Device Programme (SSDP) to integrate its Optilume Urethral Drug-Coated Balloon (DCB) into the program. This alliance allows NHS hospitals in England to receive reimbursement for the device, thereby broadening patient access to this novel device. Optilume's design combines balloon dilation with anti-proliferative drug delivery to curb urethral strictures' recurrence. It is a pioneering, minimally invasive solution, introducing a compelling substitute to conventional surgery or multiple treatments, and addresses a pressing issue within the urology fraternity.
Who Are the Key Players in the Urethral Stricture Treatment Devices Market?
Major companies operating in the urethral stricture treatment devices market are include:
• Cardinal Health
• Medtronic plc
• Siemens Healthineers AG
• Medline Industries LP.
• Becton Dickinson and Company
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun SE
• Olympus Corporation
• Coloplast Ltd
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• Cook Medical
• ConvaTec Inc.
• Ambu A/S
• Richard Wolf GmbH
• Laborie Medical Technologies
• Bactiguard AB
• UROMED Kurt Drews KG
• Pnn Medical A/S
• Hydrumedical SA
• Allium Ltd.
• Med pro Medical B.V.
• Urotronic Inc.
• Rocamed SAM
• Zhejiang ChuangXiang Medical Technology Co. Ltd
What Is The Most Dominant Region In The Urethral Stricture Treatment Devices Market?
North America was the largest region in the urethral stricture treatment devices market in 2024. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
